Episode

FSGS Drug Development No Longer a ‘Graveyard’: What Comes After Sparsentan’s Approval

Podcast
HCPLive Podcasts
Published
Apr 19, 2026
Duration seconds
827
Processing state
not_requested
Canonical source
https://audioboom.com/posts/8891929
Audio
https://audioboom.com/posts/8891929.mp3?modified=1776622253&sid=5004077&source=rss
JSON
/v1/public/podcasts/hcplive-podcasts-19526/episodes/fsgs-drug-development-no-longer-a-graveyard-what-comes-after-sparsentan-s-approval
Markdown
/podcast/hcplive-podcasts-19526/fsgs-drug-development-no-longer-a-graveyard-what-comes-after-sparsentan-s-approval.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/hcplive-podcasts-19526/episodes/fsgs-drug-development-no-longer-a-graveyard-what-comes-after-sparsentan-s-approval/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/hcplive-podcasts-19526/fsgs-drug-development-no-longer-a-graveyard-what-comes-after-sparsentan-s-approval.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

No public summary is available yet.